The Incredible Shrinking GE Turns Biopharma Into Danaher Cash

On the day it finalizes its spinoff of GE Transportation and merges it with Wabtec(WAB), GE(GE) announces an even larger divestiture, selling off its Biopharma unit to Danaher(DHR) for $21 billion in cash. Danaher will also take on $400 million in pension liabilities. GE CEO Larry Culp, former CEO of Danaher has taken another major step in shrinking… Read More »